Latest Insider Transactions at Avanos Medical, Inc. (AVNS)
This section provides a real-time view of insider transactions for Avanos Medical, Inc. (AVNS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AVANOS MEDICAL, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AVANOS MEDICAL, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,991
-4.48%
|
$89,838
$18.76 P/Share
|
|
Mar 05
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,190
-4.93%
|
$39,420
$18.76 P/Share
|
|
Mar 05
2024
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
8,431
-2.66%
|
$151,758
$18.76 P/Share
|
|
Mar 05
2024
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.68%
|
$576
$18.76 P/Share
|
|
Jan 03
2024
|
John P Byrnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+14.45%
|
-
|
|
Jan 03
2024
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+12.33%
|
-
|
|
Jan 03
2024
|
Julie Ann Shimer Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+14.45%
|
-
|
|
Jan 03
2024
|
Patrick J Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+13.29%
|
-
|
|
Jan 03
2024
|
Lisa Egbuonu Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+37.76%
|
-
|
|
Dec 11
2023
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-2.35%
|
$2,373
$21.15 P/Share
|
|
Oct 30
2023
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
562
-10.48%
|
$9,554
$17.81 P/Share
|
|
Jul 20
2023
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-1.47%
|
$17,238
$26.15 P/Share
|
|
May 08
2023
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,710
-11.67%
|
$338,330
$23.97 P/Share
|
|
May 08
2023
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,772
-3.19%
|
$40,756
$23.97 P/Share
|
|
May 08
2023
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
57,256
-15.29%
|
$1,316,888
$23.97 P/Share
|
|
Mar 06
2023
|
Arjun Ranjan Sarker Senior VP, International |
BUY
Grant, award, or other acquisition
|
Direct |
6,058
+17.65%
|
-
|
|
Mar 06
2023
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,111
-4.47%
|
$61,219
$29.62 P/Share
|
|
Mar 06
2023
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,339
+30.11%
|
-
|
|
Mar 06
2023
|
Sudhakar Varshney SVP, Global Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
12,463
+28.29%
|
-
|
|
Mar 06
2023
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.59%
|
$928
$29.62 P/Share
|
|
Mar 06
2023
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,212
+18.35%
|
-
|
|
Mar 06
2023
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,037
-2.32%
|
$88,073
$29.62 P/Share
|
|
Mar 06
2023
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,350
+21.75%
|
-
|
|
Mar 06
2023
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
8,314
-2.17%
|
$241,106
$29.62 P/Share
|
|
Mar 06
2023
|
Joseph Fralin Woody |
BUY
Grant, award, or other acquisition
|
Direct |
86,547
+18.44%
|
-
|
|
Mar 06
2023
|
William David Haydon SVP, GM Pain Franchise |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-5.05%
|
$43,877
$29.62 P/Share
|
|
Mar 06
2023
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-2.65%
|
$43,877
$29.62 P/Share
|
|
Mar 06
2023
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,233
+29.8%
|
-
|
|
Jan 03
2023
|
John P Byrnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,008
+14.53%
|
-
|
|
Jan 03
2023
|
Patrick J Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,008
+13.16%
|
-
|
|
Jan 03
2023
|
Julie Ann Shimer Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,008
+14.53%
|
-
|
|
Jan 03
2023
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,008
+12.04%
|
-
|
|
Jan 03
2023
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,726
-4.8%
|
$127,602
$27.06 P/Share
|
|
Nov 07
2022
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
615
-1.88%
|
$13,530
$22.75 P/Share
|
|
Oct 31
2022
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-10.76%
|
-
|
|
Sep 06
2022
|
David Edward Ball SVP - Global Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
3,347
-8.62%
|
$76,981
$23.87 P/Share
|
|
Jul 20
2022
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-2.41%
|
$17,901
$27.41 P/Share
|
|
Jun 09
2022
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-2.09%
|
$2,538
$27.66 P/Share
|
|
May 09
2022
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
743
-2.22%
|
$20,061
$27.74 P/Share
|
|
May 09
2022
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40
-0.88%
|
$1,080
$27.74 P/Share
|
|
Mar 04
2022
|
Joseph Fralin Woody |
BUY
Grant, award, or other acquisition
|
Direct |
80,933
+21.5%
|
-
|
|
Mar 04
2022
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,575
+23.69%
|
-
|
|
Mar 04
2022
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,233
+42.35%
|
-
|
|
Mar 04
2022
|
William David Haydon SVP, GM Pain Franchise |
BUY
Grant, award, or other acquisition
|
Direct |
12,949
+30.71%
|
-
|
|
Mar 04
2022
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,949
+27.9%
|
-
|
|
Mar 04
2022
|
Arjun Ranjan Sarker Senior VP, International |
BUY
Grant, award, or other acquisition
|
Direct |
4,671
+17.38%
|
-
|
|
Mar 04
2022
|
David Edward Ball SVP - Global Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
11,241
+28.96%
|
-
|
|
Jan 03
2022
|
Maria Sainz Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,354
+13.82%
|
-
|
|
Jan 03
2022
|
Julie Ann Shimer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,354
+13.53%
|
-
|
|
Jan 03
2022
|
John P Byrnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,354
+13.53%
|
-
|